<i>DNMT3A</i> mutation is associated with increased age and adverse outcome in adult T-cell acute lymphoblastic leukemia
Jonathan Bond(University College Dublin), Nicolas Boissel(Inserm), Mathilde Hunault(Centre National de la Recherche Scientifique), Véronique Lhéritier(Hospices Civils de Lyon), Carlos Graux(CHU Dinant Godinne UCL Namur), Gaëlle Guillerm(Inserm), Aurore Touzart(Inserm), Norbert Ifrah(Institut National du Cancer), Thibaut Leguay(Centre Hospitalier Universitaire de Bordeaux), Stéphane Leprêtre(Normandie Université), Vahid Asnafi(Hôpital Necker-Enfants Malades), Yosr Hicheri(Centre National de la Recherche Scientifique), Guillaume Hypolite(Hôpital Necker-Enfants Malades), Ludovic Lhermitte(Hôpital Necker-Enfants Malades), Elizabeth Macintyre(Inserm), Mario Bargetzi(Kantonsspital Aarau), Yves Chalandon(University of Geneva), Hervé Dombret(University of London Institute in Paris), Karin Bilger(Institut de Cancérologie Strasbourg), Françoise Huguet(Centre Hospitalier Universitaire de Toulouse)
Cited by 63
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
<i>LMO2</i> -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1
|Science|2003|3.5k